• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如此漫长的旅程:孟买耐多药结核病患者的寻医之路告诉了我们什么。

Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us.

机构信息

The Foundation for Medical Research, Worli, Mumbai, India.

出版信息

PLoS One. 2019 Jan 17;14(1):e0209924. doi: 10.1371/journal.pone.0209924. eCollection 2019.

DOI:10.1371/journal.pone.0209924
PMID:30653523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6336307/
Abstract

INTRODUCTION

The Indian Tuberculosis (TB) Programme currently faces the dual challenges of tackling increasing numbers of drug resistant (DR) TB cases and regulating practices of a pluralistic private sector catering to TB patients. A study of health seeking behaviour of DR-TB patients in such a situation, offers an opportunity to understand the problems patients face while interacting with health systems.

METHODOLOGY

Forty-six DR-TB patients drawn from 15 high TB burden wards in Mumbai were interviewed using an open ended interview tool. Interviews were audio recorded and transcribed. Pathway schematics developed from analysis of patient records, were linked to transcripts. Open coding was used to analyse these units and themes were derived after collating the codes.

RESULTS AND DISCUSSION

The paper presents themes interwoven with narratives in the discussions. These include awareness-action gap among patients, role of neighbourhood providers, responsiveness of health systems, the not-such a 'merry go round' that patients go/are made to go on while seeking care, costs of diagnostics and treatment, and how DR-TB is viewed as the 'big TB'.

CONCLUSION

The recommendations are based on a preventative ethos which is sustainable, compared to interventions with top-down approaches, which get piloted, but fail to sustain impact when scaled up.

摘要

简介

印度结核病(TB)计划目前面临着双重挑战,既要应对不断增加的耐药(DR)TB 病例,又要规范多元化私营部门为 TB 患者提供服务的做法。在这种情况下,对 DR-TB 患者的寻医行为进行研究,为了解患者在与卫生系统互动时所面临的问题提供了机会。

方法

从孟买 15 个高结核病负担病房中抽取了 46 名 DR-TB 患者,使用开放式访谈工具进行了访谈。访谈进行了录音和转录。根据患者记录分析制定的路径示意图与转录本相关联。使用开放式编码对这些单元进行分析,并在整理代码后得出主题。

结果与讨论

本文呈现了与讨论交织在一起的主题和叙述。这些主题包括患者之间的意识-行动差距、社区提供者的作用、卫生系统的响应能力、患者在寻求护理时所经历的“并非如此轻松”的过程、诊断和治疗的费用,以及如何将 DR-TB 视为“大结核病”。

结论

这些建议基于可持续的预防理念,与自上而下的干预措施相比,后者虽然进行了试点,但在扩大规模时无法维持影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/9f69155e5482/pone.0209924.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/d538265d3684/pone.0209924.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/4ff18b605932/pone.0209924.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/f6a6fb6762b9/pone.0209924.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/fcbbeb4e1b1a/pone.0209924.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/1ab41df198e0/pone.0209924.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/e41b52086833/pone.0209924.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/9f69155e5482/pone.0209924.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/d538265d3684/pone.0209924.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/4ff18b605932/pone.0209924.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/f6a6fb6762b9/pone.0209924.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/fcbbeb4e1b1a/pone.0209924.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/1ab41df198e0/pone.0209924.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/e41b52086833/pone.0209924.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da6/6336307/9f69155e5482/pone.0209924.g007.jpg

相似文献

1
Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us.如此漫长的旅程:孟买耐多药结核病患者的寻医之路告诉了我们什么。
PLoS One. 2019 Jan 17;14(1):e0209924. doi: 10.1371/journal.pone.0209924. eCollection 2019.
2
High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar.耐药结核病患者首次就医时大量选择私立医疗机构:缅甸仰光的一项横断面研究
BMC Health Serv Res. 2018 Apr 11;18(1):276. doi: 10.1186/s12913-018-3077-y.
3
Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.印度孟买大都市地区感染艾滋病毒患者中耐药结核病的惊人水平。
PLoS One. 2014 Oct 21;9(10):e110461. doi: 10.1371/journal.pone.0110461. eCollection 2014.
4
Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.印度德里一家三级医疗中心耐药结核病的流行病学及行为学关联
Indian J Tuberc. 2019 Jul;66(3):331-336. doi: 10.1016/j.ijtb.2018.06.003. Epub 2018 Jul 10.
5
"Side effects--part of the package": a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India.“副作用——治疗方案的一部分”:在印度古吉拉特邦,采用混合方法研究程序化治疗耐多药肺结核(DR-TB)患者的不良事件。
BMC Infect Dis. 2020 Dec 2;20(1):918. doi: 10.1186/s12879-020-05660-w.
6
Patients pathways to tuberculosis diagnosis and treatment in a fragmented health system: a qualitative study from a south Indian district.在一个碎片化卫生系统中患者的结核病诊断与治疗路径:来自印度南部一个地区的定性研究
BMC Public Health. 2017 Aug 4;17(1):635. doi: 10.1186/s12889-017-4627-7.
7
The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model.在印度医疗保健系统中扩大Xpert MTB/RIF用于结核病诊断的实施策略的重要性:一种传播模型
PLoS Med. 2014 Jul 15;11(7):e1001674. doi: 10.1371/journal.pmed.1001674. eCollection 2014 Jul.
8
Pulmonary tuberculosis in Patna, India: Durations, delays, and health care seeking behaviour among patients identified through household surveys.印度巴特那的肺结核:通过家庭调查确定的患者的病程、延误情况及就医行为
J Epidemiol Glob Health. 2017 Dec;7(4):241-248. doi: 10.1016/j.jegh.2017.08.001. Epub 2017 Aug 10.
9
The making of a public health problem: multi-drug resistant tuberculosis in India.公共卫生问题的产生:印度的耐多药结核病。
Health Policy Plan. 2013 Jul;28(4):375-85. doi: 10.1093/heapol/czs069. Epub 2012 Aug 3.
10
Tapping private health sector for public health program? Findings of a novel intervention to tackle TB in Mumbai, India.利用私营医疗部门服务公共卫生项目?印度孟买结核病新干预措施的发现。
Indian J Tuberc. 2020 Apr;67(2):189-201. doi: 10.1016/j.ijtb.2020.01.007. Epub 2020 Jan 22.

引用本文的文献

1
Experiences of children and their caregivers affected by multidrug-resistant tuberculosis in Cape Town, South Africa.南非开普敦受耐多药结核病影响的儿童及其照料者的经历。
PLoS One. 2025 May 19;20(5):e0323492. doi: 10.1371/journal.pone.0323492. eCollection 2025.
2
A methodological review of patient healthcare-seeking journeys from symptom onset to receipt of care.对患者从症状出现到接受治疗的就医过程的方法学综述。
BMJ Glob Health. 2025 May 16;10(5):e016978. doi: 10.1136/bmjgh-2024-016978.
3
Putting people at the center: methods for patient journey mapping of viral hepatitis services across two LMICs in the Asia Pacific.

本文引用的文献

1
Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India.印度一家三级护理医院治疗耐多药结核病患者的灾难性费用。
Indian J Tuberc. 2019 Jan;66(1):87-91. doi: 10.1016/j.ijtb.2018.04.011. Epub 2018 Apr 17.
2
Pathway to care for drug resistant tuberculosis cases identified during a retrospective study conducted in high TB burden wards in Mumbai.在孟买结核病高负担病房进行的一项回顾性研究中确定的耐多药结核病病例的护理途径。
Gates Open Res. 2018 May 10;2:9. doi: 10.12688/gatesopenres.12785.2. eCollection 2018.
3
Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis.
以人为本:亚太地区两个低收入和中等收入国家病毒性肝炎服务患者旅程映射方法
BMC Health Serv Res. 2025 Mar 25;25(1):427. doi: 10.1186/s12913-025-12543-w.
4
Health-seeking pathway of drug-resistant TB patients in Vadodara, India.印度瓦多达拉耐药结核病患者的寻医途径。
Public Health Action. 2023 Dec;13(4):155-161. doi: 10.5588/pha.23.0019. Epub 2023 Dec 7.
5
Intersections of informal work status, gender and tuberculosis diagnosis: Insights from a qualitative study from an Indian setting.非正式工作状态、性别与结核病诊断的交织:来自印度背景的定性研究的见解。
PLoS One. 2023 Jul 27;18(7):e0289137. doi: 10.1371/journal.pone.0289137. eCollection 2023.
6
Tuberculosis diagnosis and management in the public versus private sector: a standardised patients study in Mumbai, India.公私营部门结核病诊断和管理:印度孟买的标准化患者研究。
BMJ Glob Health. 2022 Oct;7(10). doi: 10.1136/bmjgh-2022-009657.
7
Living with tuberculosis: a qualitative study of patients' experiences with disease and treatment.与结核病共存:一项关于患者疾病和治疗体验的定性研究。
BMC Public Health. 2022 Sep 10;22(1):1717. doi: 10.1186/s12889-022-14115-7.
8
Contributing Factors in the Tuberculosis Care Cascade in India: A Systematic Literature Review.印度结核病治疗流程中的影响因素:一项系统文献综述
Risk Manag Healthc Policy. 2021 Aug 10;14:3275-3286. doi: 10.2147/RMHP.S322143. eCollection 2021.
9
Initial loss to follow up of tuberculosis patients in South Africa: perspectives of program managers.南非结核病患者随访初期失访情况:项目管理者的观点。
BMC Public Health. 2020 May 6;20(1):622. doi: 10.1186/s12889-020-08739-w.
10
Quality of drug-resistant tuberculosis care: Gaps and solutions.耐多药结核病护理质量:差距与解决方案。
J Clin Tuberc Other Mycobact Dis. 2019 Apr 24;16:100101. doi: 10.1016/j.jctube.2019.100101. eCollection 2019 Aug.
中低收入国家肺结核诊断延迟:系统评价和荟萃分析。
BMC Pulm Med. 2017 Dec 13;17(1):202. doi: 10.1186/s12890-017-0551-y.
4
Pulmonary tuberculosis in Patna, India: Durations, delays, and health care seeking behaviour among patients identified through household surveys.印度巴特那的肺结核:通过家庭调查确定的患者的病程、延误情况及就医行为
J Epidemiol Glob Health. 2017 Dec;7(4):241-248. doi: 10.1016/j.jegh.2017.08.001. Epub 2017 Aug 10.
5
TB Notification from Private Health Sector in Delhi, India: Challenges Encountered by Programme Personnel and Private Health Care Providers.印度德里私立医疗部门的结核病通报:项目人员和私立医疗服务提供者面临的挑战
Tuberc Res Treat. 2017;2017:6346892. doi: 10.1155/2017/6346892. Epub 2017 Aug 6.
6
Patients pathways to tuberculosis diagnosis and treatment in a fragmented health system: a qualitative study from a south Indian district.在一个碎片化卫生系统中患者的结核病诊断与治疗路径:来自印度南部一个地区的定性研究
BMC Public Health. 2017 Aug 4;17(1):635. doi: 10.1186/s12889-017-4627-7.
7
Tuberculosis burden in India's private sector.印度私营部门的结核病负担。
Lancet Infect Dis. 2016 Dec;16(12):1328-1329. doi: 10.1016/S1473-3099(16)30470-4. Epub 2016 Nov 15.
8
Health Seeking Behaviour among Tuberculosis Patients in India: A Systematic Review.印度结核病患者的就医行为:一项系统评价
J Clin Diagn Res. 2016 Oct;10(10):LE01-LE06. doi: 10.7860/JCDR/2016/19678.8598. Epub 2016 Oct 1.
9
The number of privately treated tuberculosis cases in India: an estimation from drug sales data.印度接受私人治疗的结核病病例数:基于药品销售数据的估计
Lancet Infect Dis. 2016 Nov;16(11):1255-1260. doi: 10.1016/S1473-3099(16)30259-6. Epub 2016 Aug 25.
10
Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India.耐多药结核病(MDR-TB)的管理与控制:满足印度的政策需求
J Public Health Policy. 2016 Aug;37(3):277-299. doi: 10.1057/jphp.2016.14. Epub 2016 May 6.